Ixazomib
45 interactions 278 cited referencesIxazomib is used in combination with lenalidomide (Revlimid) and dexamethasone to treat multiple myeloma (cancer of the plasma cells in the bone marrow) that has worsened after treatment with other chemotherapy medications. Ixazomib is in a class of medications called proteasome inhibitors. It works by helping to kill… Read the full Ixazomib drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Ixazomib Abametapir Increased exposure of CYP3A4 substrate Details Ixazomib Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Ixazomib Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Ixazomib Apalutamide Erleada Reduced CYP3A4 substrate exposure Details Ixazomib Avacopan Tavneos Increased CYP3A4 substrate exposure Details Ixazomib Carbamazepine Carbatrol Decreased ixazomib exposure Details Ixazomib Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Ixazomib Clarithromycin Biaxin Increased exposure of CYP3A4 substrate and risk for toxicity Details Ixazomib Conivaptan Vaprisol Increased CYP3A substrate exposure Details Ixazomib Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Ixazomib Enzalutamide Xtandi Decreased ixazomib exposure Details Ixazomib Erythromycin Erythrocin Stearate Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse effects Details Ixazomib Fedratinib Inrebic Increased CYP3A4 substrate exposure Details Ixazomib Fexinidazole An increased CYP3A4 substrate exposure Details Ixazomib Fosphenytoin Cerebyx Decreased ixazomib exposure Details Ixazomib Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Ixazomib Itraconazole Sporanox Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details Ixazomib Letermovir Prevymis Increased CYP3A substrate exposure Details Ixazomib Mifepristone Korlym Increased CYP3A4 substrate exposure Details Ixazomib Mitotane Lysodren Decreased ixazomib exposure Details Ixazomib Omaveloxolone Skyclarys Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Ixazomib Phenobarbital Fidoquel Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Ixazomib Phenytoin Dilantin Decreased ixazomib exposure Details Ixazomib Primidone Mysoline Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Ixazomib Relacorilant Lifyorli Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse reactions Details Ixazomib Rifampin Rifadin Decreased ixazomib exposure Details Ixazomib Rotavirus Vaccine, Live An increased risk of infection by the live vaccine Details Ixazomib St John's Wort Decreased ixazomib exposure Details Ixazomib Tazemetostat Tazverik Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Ixazomib Voriconazole Vfend Increased CYP3A4 substrates exposure and an increased efficacy of CYP3A4 substrates-related adverse effects Details Ixazomib Letermovir Injection Prevymis Increased CYP3A substrate exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist